Augmentation of Limb Perfusion With Contrast Ultrasound

Recruiting now · Not applicable

Conditions studied: Peripheral Arterial Disease

In brief

Our laboratory has discovered that ultrasound (US) imaging together with clinically approved microbubble ultrasound contrast agents can augment limb tissue perfusion. These observations have been made in mice with and without peripheral artery disease (PAD), and also in humans where high power contrast enhanced ultrasound (CEU) was used to measure perfusion but was found also to augment perfusion by almost 2-fold. The latter human studies were performed with ultrasound protocols designed for perfusion imaging and not for flow augmentation. In this study, we will measure the degree to which limb perfusion is augmented with specific therapeutic CEU settings that are still within the FDA-approved limits with regards to US power and contrast dosing.

Key facts

Study ID
NCT03195556
Run by
Oregon Health and Science University
People needed
30
Starts
2018-06-18
Expected to finish
2019-12-01
Last updated by the study team
2018-08-23

Who can join

Age: 19 and older, up to 99. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.